Drug Interactions clinical trials

Explore recruiting drug interactions clinical trials.

Recruiting drug interactions studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Drug Interactions trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A study to learn about how different drugs interact with each drug in a new 7-drug mixture as they move into, through, and out of the body in healthy men

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Phase 2a, multi centric, open label clinical study to explore the safety and tolerability, the pharmacokinetics and pharmacodynamics profile and first signs of efficacy of PTI5803 administered as adjunctive therapy with a 3-dose escalation regimen in patients >= 14 years of age with drug-resistant seizures associated to focal cortical dysplasia, followed by an optional open-label extension study.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Investigation of Drug-Drug Interactions between LVDS (Levonorgestrel Vaginal Delivery System) and Miconazole in Healthy Female Participants.

Portugal

Human Pharmacology (Phase I)- Other EU CTIS Study details

Investigate Drug-Drug Interactions between LVDS (Levonorgestrel Vaginal Delivery System) and Tampons and Lubricants in Healthy Female Participants

Portugal

Human Pharmacology (Phase I)- Other EU CTIS Study details

A phase 1, Pharmacokinetic Comparison of Vonafexor Acid and Its Lysine Salt (EYP651) and Evaluation of Potential Drug-Drug Interactions.

France

Human Pharmacology (Phase I)- Other EU CTIS Study details

A phase 1B of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies

Germany, Italy, France, Spain, Netherlands, Denmark +3 more

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Drug Interactions trials by city

Drug Interactions in Toronto Drug Interactions in Vancouver Drug Interactions in Montreal Drug Interactions in Calgary Drug Interactions in Edmonton Drug Interactions in Ottawa Drug Interactions in Winnipeg Drug Interactions in Quebec City Drug Interactions in Hamilton Drug Interactions in Kitchener Drug Interactions in London Drug Interactions in Halifax Drug Interactions in New York Drug Interactions in Los Angeles Drug Interactions in Chicago Drug Interactions in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease